GlassScriptPhysician profile
Matt Allen Douglas
NPI 1750354643
$1,598.69
in general payments reported to CMS, 2019-2025
19 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.80 · 2022: $132 · 2023: $339 · 2024: $575 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,381.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $550.05 | 2022-2025 | Gallant, Merlin@Home, Aveir |
| Novartis Pharmaceuticals Corporation | $315.39 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.24 | 2022-2025 | Jardiance |
| Medtronic, INC. | $121.08 | 2021-2025 | Linq II, Micra |
| E.R. Squibb & Sons, L.L.C. | $97.68 | 2022-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.50 | 2024-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $44.62 | 2022-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $32.41 | 2023 | Verquvo |
| Cvrx, INC. | $26.92 | 2022-2023 | Barostim Neo System |
| Baxter Healthcare | $26.14 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Surmodics, INC. | $24.81 | 2023 | Pounce Venous Thrombectomy System, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Astrazeneca Pharmaceuticals LP | $23.89 | 2023 | Andexxa |
| Genzyme Corporation | $21.89 | 2024 | |
| Boston Scientific Corporation | $21.40 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $17.02 | 2024 | Arcalyst |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coala Life INC | $16.51 | 2021 | |
| Philips North America LLC | $16.07 | 2024 | (Ck4) Mcot |
| Amgen INC. | $13.74 | 2025 | Repatha |
| Pfizer INC. | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matt Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.